Arcus Biosciences Names Richard Markus, M.D., Ph.D. as Chief Medical Officer
Arcus Biosciences Appoints Richard Markus, M.D., Ph.D., as Chief Medical Officer Arcus Bioscience a clinical-stage biopharmaceutical Officer company focused on developing novel molecules and combination therapies for cancer treatment, has…
Salubris Biotherapeutics Reports Positive Interim Data from Phase 2 Heart Failure Trial of JK07
Salubris Biotherapeutics Announces Positive Interim Data from Phase 2 Trial of JK07 in Heart Failure Salubris Biotherapeutics a clinical-stage biotechnology company focused on developing innovative biologic therapies, has announced promising…
Roche Gets FDA Clearance for CLIA-Waived STI Point-of-Care Tests
Roche Receives FDA Clearance for CLIA-Waived STI Point-of-Care Tests Roche has announced a major milestone in the realm of sexual health diagnostics. The U.S. Food and Drug Administration (FDA) has…
Sarclisa Approved in EU for Treating Transplant-Ineligible Newly Diagnosed Multiple Myeloma
European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), the EU has approved Sarclisa in combination with a standard-of-care regimen—bortezomib, lenalidomide, and dexamethasone (VRd)—for the treatment of…
Phase 2 Trial: Cytokinetics Launches AMBER-HFpEF Study of CK-586 in Symptomatic HFpEF
Introduction: Cytokinetics Advances CK-586 into Phase 2 Trial Cytokinetics, Incorporated a leading biopharmaceutical company, has announced that enrollment is now open for AMBER-HFpEF, a pivotal Phase 2 clinical trial evaluating…
BrainChild Bio Receives Prestigious G-Rex® Grant from ScaleReady
BrainChild Bio Receives Recognition for Innovation in Cell Therapy ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, has announced that BrainChild Bio has been awarded a $300,000…
WHO Responds to U.S. Announcement of Withdrawal Intent
WHO Expresses Regret Over U.S. Withdrawal Announcement The World Health Organization (WHO) has expressed deep regret over the announcement that the United States intends to withdraw from the Organization. The…
Poxel to Gain Increased Royalties from Sumitomo Pharma for TWYMEEG Sales in Japan
Poxel Achieves Milestone with TWYMEEG® Sales in Japan, Secures Royalties and Sales-Based Payments Poxel, a clinical-stage biopharmaceutical company focused on innovative treatments for chronic serious diseases with metabolic pathophysiology—including metabolic…
Poxel Secures Patent in China for Imeglimin Use in Type-2 Diabetic Patients with Renal Impairment
Poxel Advances Global Strategy with Key Patent for Imeglimin in China Expanding Innovative Treatments for Chronic Metabolic Diseases Poxel, a clinical-stage biopharmaceutical company focused on developing cutting-edge treatments for chronic…
Aseptic Filling Machine Market Forecast to 2035 Key Players Profiled
Aseptic Filling Machine Market: Industry Trends and Global Forecasts to 2035 The global market for aseptic filling machines has witnessed remarkable growth over recent years, driven by advancements in pharmaceutical…
Gaza Ceasefire Brings Hope, but Health System Challenges Remain
WHO Welcomes Gaza Ceasefire but Highlights Immense Health Challenges Ahead The World Health Organization (WHO) has welcomed the Gaza ceasefire and the associated hostage and prisoner release deal, bringing a…
Leaps by Bayer Launches Global Survey on Breakthrough Tech Attitudes
Global Survey Explores Public Sentiment on Breakthrough Technologies As Global Survey leaders convene for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm…